A Randomized Controlled Trial on Seretide Combined withShiwei Longdanhua Granule in Treatment of Chronic Asthma Duration
10.3969/j.issn.1005-5304.2015.11.006
- VernacularTitle:舒利迭联合十味龙胆花颗粒治疗支气管哮喘慢性持续期随机对照试验
- Author:
Lujiong LIU
- Publication Type:Journal Article
- Keywords:
Seretide;
Shiwei Longdanhua Granule;
asthma;
distance of 6-minute walk
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2015;22(11):20-23
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of Seretide combined withShiwei Longdanhua Granule in the treatment of chronic asthma duration.Methods Totally 110 patients with chronic asthma duration were randomly divided into treatment group and control group, 55 cases in each group. They inhaled Seretide 50/250μg, once in morning and evening, as a basic treatment. The treatment group was treated combined with oralShiwei Longdanhua Granule, 1 package each time, 3 times a day. The control group was treated combined with oral compound Methoxyphenamine, 2 capsules each time, 3 times a day. The course lasted for 7 days. The clinical symptoms, physical signs and the distance of 6-minute walk of the two groups were observed. Results After treatment, the clinical symptoms, physical signs and the distance of 6-minute walk of the two groups improved, without statistical significance between the two groups (P>0.05). Conclusion Inhaled Seretide combined with oralShiwei Longdanhua Granule for short period can improve the clinical syndromes and the distance of 6-minute walk, without statistical significance with Seretide combined with oral Methoxyphenamine.
